Resultados de la búsqueda 891-900 of 11424 for 力曼保養品好用嗎加:💗line:sammibaby💗瞭解更多👜感謝您對力曼的信任與支持！ 我們將秉持著一貫的品質和服務標準,為您帶來更多驚喜和滿意！👗连江县刮油最好的减肥方法🦆万华区韓國化妝品男士

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this trial is to compare denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation. A ...

  2. Medicina de Trasplante Resource Center - Profesionales médicos - Mayo Clinic

    Transplant Resource Center for Medical Professionals including clinical updates, news, videos, continuing education and calculators from Mayo Clinic.

  3. Oncología (médica) - Ensayos clínicos

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  4. Oncología (médica) - Ensayos clínicos

    This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following standard of care ...

  5. Oncología (médica) - Ensayos clínicos

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase I trial is looking to see if sargramostim given with a nebulizer, in combination with standard immune checkpoint inhibitor therapy ...

  7. Clínica de las mamas - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to prospectively evaluate the patient-reported outcomes data of T-DM1 induced peripheral neuropathy like prior ...

  8. La salud de los niños Más información - Mayo Clinic

  9. Ensayos clínicos - Neurología

    The purpose of this study is to evaluate the use of a smartphone app for stroke patients with obstructive sleep apnea in order to better use their positive ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to characterize the safety and tolerability of MRTX849 in patients having advanced solid tumor malignancies with KRAS G12C mutation ...